GRI Bio, Inc. (GRI)
NASDAQ: GRI · Real-Time Price · USD
2.500
-0.065 (-2.53%)
Mar 9, 2026, 4:00 PM EDT - Market closed
GRI Bio Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 4 | 2 | 7 | 2 | - | - | |
| Market Cap Growth | -7.08% | -66.25% | 326.73% | - | - | - | |
| Enterprise Value | -5 | -1 | 3 | -2 | - | - | |
| Last Close Price | 2.50 | 6.91 | 394.32 | 16674.51 | - | - | |
| PB Ratio | 0.21 | 0.42 | 1.84 | 6.70 | - | - | |
| P/TBV Ratio | 0.60 | 0.42 | 1.84 | 6.70 | - | - | |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.03 | 0.05 | -0.41 | -0.74 | |
| Net Debt / Equity Ratio | -1.36 | -1.36 | -1.22 | -6.93 | -0.41 | -0.73 | |
| Net Debt / EBITDA Ratio | 0.68 | 0.68 | 0.60 | 0.16 | -0.30 | -3.33 | |
| Net Debt / FCF Ratio | 0.80 | 0.80 | 0.57 | 0.20 | -0.61 | -4.16 | |
| Quick Ratio | 3.11 | 3.11 | 3.07 | 0.67 | 0.01 | 0.02 | |
| Current Ratio | 3.25 | 3.25 | 3.43 | 1.09 | 0.16 | 0.02 | |
| Return on Equity (ROE) | -238.17% | -238.17% | -382.52% | - | - | - | |
| Return on Assets (ROA) | -103.93% | -103.93% | -118.39% | -416.93% | -465.68% | -226.54% | |
| Return on Capital Employed (ROCE) | -198.90% | -198.90% | -200.70% | -4300.00% | 139.00% | 22.80% | |
| Earnings Yield | -330.96% | -478.65% | -110.90% | -751.78% | - | - | |
| FCF Yield | -282.04% | -407.91% | -116.36% | -518.87% | - | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.